Tags Result
Ibnsina Pharma has signed a cooperation protocol with fintech company Stryve to provide pharmacies with enhanced electronic payment options.
Updated 11/14/2024 9:28:00 AM
Ibnsina is an Egypt-based pharmaceutical distribution company, with a diversified portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers.
Updated 3/1/2023 2:02:00 AM
Ibnsina Pharma’s (ISPH) board of directors has endorsed cutting the company’s issued capital to EGP 257.641 million from EGP 279.041 million, according to a statement filed to the Egyptian Exchange (EGX) on December 25th. The issued capital will be reduced by writing off 85.6 million treasury shares that account for 7.6% of the company’s capital.
Updated 2/8/2023 11:34:00 PM
Ibnsina Pharma (ISPH) has signed an agreement with the German Boehringer Ingelheim to distribute the latter’s treatments across cardiovascular, cardio-renal-metabolic, and respiratory therapeutic areas in Egypt, according to a press release on February 5th. "Boehringer Ingelheim's partnership with Ibnsina will further strengthen our leadership position in Egypt and highlights our commitment towards delivering sustainable solutions and treatments to our patients,” Marianne Abou Elkheir, General Manager and Head of Human Pharma at Boehringer Ingelheim, LINEA, and SSA, said.
Updated 2/5/2023 11:23:00 AM